This is a study to determine the effectiveness of a combination of SYR-322 and pioglitazone HCI (Actos) as compared to pioglitazone HCI alone in treating Type 2 diabetes. This national study is currently recruiting patients.
Read moreIf you take medication for ADHD symptoms, chances are you use a stimulant medication such as Adderall, Ritalin or Concerta. These types of... Read more »
Good news for everyone who has been affected by the oxycodone shortage! This week the FDA approved Sun Pharmaceutical Industries'... Read more »
Hello everyone! I hope you all are having a decent week. I don't know about you but I just can't get used to these days getting dark... Read more »
By Dr. Cindy Haines, author of The New Prescription: How to Get the Best Health Care in a Broken System (HCI Books, May 2011) Americans... Read more »
The Food and Drug Administration has approved Geodon (Ziprasidone) as a maintenance treatment for bipolar I disorder. After a six month... Read more »
This is a Phase 4 clinical trial to determine the effectiveness of using atomoxetine in children age 10 to 16 who have ADHD as well as dyslexia. The... Read more »
A new British study has shown that children with attention-deficit hyperactivity disorder (ADHD) who take Strattera (atomoxetine) to control the... Read more »
Data from 13 clinical trials has shown that after two years on Strattera, teens with attention-deficit/hyperactivity disorder (ADHD) continue to show... Read more »
Source: First DataBank
Generic Name: ATOMOXETINE - ORAL Pronounced: (at-oh-MOX-eh-teen) Uses Atomoxetine is used to treat attention-deficit hyperactivity disorder... Read more »
Health Canada has received two reports linking the attention-deficit/hyperactivity disorder (ADHD) drug Strattera with tics in children. In one case,... Read more »